Elder Pharmaceuticals (Delisted) share news and announcements

BSE: 532322

Last traded ₹38.00 on 12 Sep 2016

Delisted on 11 May 2018.

Elder Pharmaceuticals share news and announcements

562 announcements, routine notices left out, newest first. Page 4 of 12.

Apr 2014
- 1 Apr · Disclosure
  Indarts Exports Pvt Ltd has now submitted the revised disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 1 Apr · Disclosure
  Semit Pharmaceuticals & Chemiclas Ltd has now submitted the revised disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
Mar 2014
Feb 2014
- 20 Feb · Legal
  Clarification as under: "This refers to the news item appeared today in The Hindu and other news papers. In this connection, ....
- 20 Feb · Legal
  Exchange had sought clarification from Elder Pharmaceuticals Limited with respect to a news item captioned "Elder Pharma in revamp mode". The Company has clarified that "the Company has informed the Exchange on December 13,2013 about the sale of its formulation business in India and Nepal to Torrent Pharmaceuticals Limited. Post this deal, the Company's overall strategy is to focus on its remaining brands inclusive Eldervit and Somazina and position itself further in the growing neutraceuticals segment by launching more products of its own. Also the Company is also planning to concentrate and build on its domestic business of anti-infectives, strength its in-licence portfolio and grow its business in UK and Europe. Hence the Company has decided to have a strategic planning or realigning the group post the deal for which have decided to appoint Deloitte for advising on the reworking of the Company post the transaction with torrent."
- 20 Feb · Board meeting
  Board of Directors of the Company at its meeting held on February 14, 2014, inter alia, has approved the following: 1. Resignation ....
- 14 Feb · Results
  Standalone & consolidated financial results for the period ended 31-Dec-2013. (opens in a new tab)
- 14 Feb · Results
  Financial Results & a copy of the Limited Review Report for the period ended December 31, 2013. (opens in a new tab)
- 10 Feb · Disclosure of Voting Pattern - Clause 35A
  Voting result of the Postal Ballot held on February 10, 2014 under Clause 35A of the Listing Agreement. (opens in a new tab)
- 10 Feb · Results
  Details of Voting results of Postal Ballot, under Clause 35A. (opens in a new tab)
- 6 Feb · Disclosure
  Indarts Exports Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 5 Feb · Disclosure
  Vide letter dated February 03, 2014 a copy of Disclosure in terms of Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
Jan 2014
Dec 2013
- 30 Dec · Meeting
  Outcome of Annual General Meeting of the Company held on December 30, 2013. (opens in a new tab)
- 30 Dec · Meeting
  The 30th Annual General Meeting (AGM) of the Company was held on December 30, 2013. (opens in a new tab)
- 27 Dec · Disclosure
  Akshaya Holding Pvt Ltd has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 27 Dec · Disclosure
  Akshaya Holdings Pvt Ltd has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 26 Dec · Disclosure
  Vide letter dated December 19, 2013 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992. (opens in a new tab)
- 24 Dec · Meeting
  The 30th Annual General Meeting (AGM) of the Company will be held on December 30, 2013. (opens in a new tab)
- 18 Dec · Meeting
  Company has fixed Book Closure from December 23, 2013 to December 30, 2013 (both days inclusive) for the purpose of Annual General Meeting of the Company to be held on December 30, 2013.
- 13 Dec · Business
  Meeting of the empowered Committee of the Board of the Company was held on December 13, 2013 and the said Committee has approved the definitive agreement and entered into Business Transfer Agreement (BTA) for the sale of domestic formulation business to Torrent Pharmaceuticals Ltd. Further the Company has submitted a copy of the press release dated December 13, 2013, titled, "Torrent to Acquire Indian Branded Formulations Business of Elder". (opens in a new tab)
- 13 Dec · Torrent to Acquire Indian Branded Formulations Business of Elder
  Meeting of the empowered Committee of the Board of the Company was held on December 13, 2013 and the said Committee has approved the definitive .... (opens in a new tab)
Nov 2013
- 29 Nov · Disclosure
  Semit Pharmaceuticals & Chemicals Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)